Literature DB >> 1717128

Total gastrectomy for advanced cancer. A worthwhile palliative procedure.

J R Monson1, J H Donohue, D C McIlrath, M B Farnell, D M Ilstrup.   

Abstract

Subtotal gastric resection usually provides the best palliation in advanced gastric cancer; however, if total gastrectomy (TG) is required there is doubt about its benefit. The authors reviewed 53 consecutive patients undergoing TG for advanced gastric adenocarcinoma between 1980 and 1989. Indications for TG were tumor location in 30% and extent of tumor in 70%, including nine patients (17%) with linitis plastica. Four patients (8%) died postoperatively, and six patients required reoperation for postoperative complications. The median postoperative hospital stay was 13 days. The median survival was 19 months, and 13 patients (24%) lived for more than 2 years. The quality of life was graded in survivors as good in 59%, satisfactory in 28%, and poor in 13% of patients. It was concluded that TG is a worthwhile procedure for selected patients, even in the presence of advanced disease, providing prolongation of good quality of life with low morbidity and mortality.

Entities:  

Mesh:

Year:  1991        PMID: 1717128     DOI: 10.1002/1097-0142(19911101)68:9<1863::aid-cncr2820680902>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

Review 1.  A systematic review of surgery for non-curative gastric cancer.

Authors:  Alyson L Mahar; Natalie G Coburn; Simron Singh; Calvin Law; Lucy K Helyer
Journal:  Gastric Cancer       Date:  2011-10-28       Impact factor: 7.370

2.  The clinical value of non-curative resection followed by chemotherapy for incurable gastric cancer.

Authors:  Kyung Jai Ko; Jung Ho Shim; Han Mo Yoo; Seong Il O; Hae Myung Jeon; Cho Hyun Park; Dong Jin Jeon; Kyo Young Song
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

Review 3.  Non-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature.

Authors:  Yves Dittmar; Falk Rauchfuss; Max Goetz; Karin Jandt; Hubert Scheuerlein; Michael Heise; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2012-02-04       Impact factor: 3.445

Review 4.  Current role of surgical therapy in gastric cancer.

Authors:  Ryan Swan; Thomas J Miner
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

5.  Is there a role for palliative gastrectomy in patients with stage IV gastric cancer?

Authors:  Reza F Saidi; Stephen G ReMine; Paul S Dudrick; Nader N Hanna
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

6.  Survival benefit of non-curative gastrectomy for gastric cancer patients with synchronous distant metastasis.

Authors:  Chen Li; Min Yan; Jun Chen; Min Xiang; Zheng Gang Zhu; Hao Ran Yin; Yan Zheng Lin
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

Review 7.  Gastric cancer.

Authors:  P McCulloch
Journal:  Postgrad Med J       Date:  1996-08       Impact factor: 2.401

8.  An integrated, self-expanding, Y-shaped, metallic stent for patients with complex obstruction after gastrojejunostomy (Billroth II): initial experience.

Authors:  G Wu; Y-D Li; X-W Han; P-X Ding
Journal:  Radiol Med       Date:  2011-03-19       Impact factor: 3.469

9.  Clinicopathologic characteristics of gastric cancer patients who underwent noncurative gastrectomy with long-term survival.

Authors:  Hiroaki Saito; Yoshinori Yamada; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  Langenbecks Arch Surg       Date:  2008-08-02       Impact factor: 3.445

10.  Hepatoid adenocarcinoma of the stomach - a different histology for not so different gastric adenocarcinoma: a case report.

Authors:  Elisa Gálvez-Muñoz; Javier Gallego-Plazas; Verónica Gonzalez-Orozco; Francisco Menarguez-Pina; José A Ruiz-Maciá; Miguel A Morcillo
Journal:  Int Semin Surg Oncol       Date:  2009-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.